The new guidelines focus on helping clinicians decide when to initiate, switch, or discontinue disease-modifying therapies for multiple sclerosis.

Neurology Advisor will provide live coverage of the 2018 American Academy of Neurology Annual Meeting from Los Angeles, CA.